ArticleEJNMMI radiopharmacy and chemistry2021
One-pot and one-step automated radio-synthesis of [
Article in EJNMMI radiopharmacy and chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05442151 (Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts), which is not on this map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts
Who cites it
16 citing papers in PubMed, 24 citations in OpenAlex.
- Automated and manual synthesis of [EJNMMI radiopharmacy and chemistry · 2026Article
- Combined antitumor activity of [EJNMMI research · 2026Article
- cGMP-compliant high-yield automated production of [EJNMMI radiopharmacy and chemistry · 2025Article
- Optimizing [EJNMMI research · 2025Article
- Production and Quality Control of [Pharmaceuticals (Basel, Switzerland) · 2025Article
- Monovalent and Divalent Designs of Copper Radiotheranostics Targeting Fibroblast Activation Protein in Cancer.Cancers · 2024Article
- Review
- Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T-cell therapy in solid tumors.Cancer science · 2024Review
- Evaluation of Targeted Alpha Therapy Using [International journal of molecular sciences · 2024Article
- Article
- Impact ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023Article
- Initial Evaluation of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023Article
- Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine.International journal of molecular sciences · 2023Article
- Article
- From Automated Synthesis to In Vivo Application in Multiple Types of Cancer-Clinical Results with [Pharmaceuticals (Basel, Switzerland) · 2022Article
- FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century.Frontiers in oncology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 6 institutions in 3 countries.
Funding
Abstract
backgroundFibroblast activation protein (FAP) is overexpressed in the stroma of many types of cancer. [
resultsRadiosynthesis of [
conclusionsWe established a one-pot one-step automated synthesis method using a CFN-MPS200 synthesizer that provided high radioactivity and stable radiochemical purity for possible clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.